2562-69-8 Usage
Uses
Used in Pharmaceutical Industry:
2-[3,4-(METHYLENEDIOXY)PHENYL]-BENZIMIDAZOLE is used as a potential drug candidate for its anti-inflammatory and anti-cancer effects. Its interaction with various biological targets, such as enzymes and receptors, makes it a promising compound for the treatment of certain diseases.
Used in Medicinal Chemistry Research:
2-[3,4-(METHYLENEDIOXY)PHENYL]-BENZIMIDAZOLE serves as an interesting target for further research and development in the field of medicinal chemistry. Its unique chemical structure and properties hold potential for the discovery of new therapeutic agents and the advancement of drug design strategies.
Check Digit Verification of cas no
The CAS Registry Mumber 2562-69-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,5,6 and 2 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 2562-69:
(6*2)+(5*5)+(4*6)+(3*2)+(2*6)+(1*9)=88
88 % 10 = 8
So 2562-69-8 is a valid CAS Registry Number.
InChI:InChI=1/C14H10N2O2/c1-2-4-11-10(3-1)15-14(16-11)9-5-6-12-13(7-9)18-8-17-12/h1-7H,8H2,(H,15,16)
2562-69-8Relevant academic research and scientific papers
CuI-catalyzed amination of arylhalides with guanidines or amidines: A facile synthesis of 1-H-2-substituted benzimidazoles
Deng, Xiaohu,McAllister, Heather,Mani, Neelakandha S.
supporting information; experimental part, p. 5742 - 5745 (2009/12/06)
(Figure Presented) CuI/L5 (N,N′-dimethylethylenediamine) proves to be an efficient catalyst system for the amination of arylhalides with guanidines. The same catalyst system is then successfully applied to the one-step synthesis of 1-H-2-aminobenzimidazol
